We next examined whether a pro-inflammatory environment characterized by the pro-inflammatory cytokines IFNγ, TNFα, and IL-1β, all associated with IBD-pathophysiology, would alter the expression of CEACAMs. The gene discussed is IFNG; the disease is inflammatory bowel disease.